SUBSCRIBERS
Endofotonics raises S$12m in Series B funding, led by Singapore Medical Group
Published Fri, May 29, 2020 · 09:50 PM
Singapore
CANCER diagnostic company Endofotonics on Friday said it has raised S$12 million in a Series B round led by executives from locally listed healthcare company Singapore Medical Group.
The additional funding will be used to drive commercialisation of its early gastric cancer detection system in the Asia-Pacific, and to expand the coverage of its cancer detection technology to other organs.
KEYWORDS IN THIS ARTICLE
BT is now on Telegram!
For daily updates on weekdays and specially selected content for the weekend. Subscribe to t.me/BizTimes
Companies & Markets
OpenAI inks licensing deal with People magazine publisher
Apple unveils new AI-focused chip in upgraded iPad Pro models
DBS CEO Piyush Gupta sells S$2.7 million worth of bank shares
Disney's surprise streaming entertainment profit offset by weaker TV business
Geely, Foretellix partner to jump-start self driving car development
US: Wall Street opens slightly higher on rate cut optimism